• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY Back to Search Results
Model Number PP6-530-0027-US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Clouding/Hazing (1878); Loss of Vision (2139); Visual Disturbances (2140); Halo (2227)
Event Type  Injury  
Manufacturer Narrative
The inlay remains implanted at the time of this report and is therefore not available for evaluation.The device history record review of the manufacturing lot was performed and there were no discrepancies or unusual findings related to the reported issue.Corneal haze, decreased vision, and increased visual symptoms are listed in the device labeling as known potential risks.(b)(4).
 
Event Description
The subject was enrolled in the ide clinical trial and underwent implantation of the investigational corneal inlay in the right eye on (b)(6) 2013.Six months postoperatively, the patient presented with grade 2 central corneal haze in the operative eye, with recurrent haze throughout the course of the study.The haze was associated with visual disturbances (halos, glare, double vision, and ghost images) that significantly interfered with the activities of daily living, including driving at night and depth perception.The corneal haze resulted in a decrease in best corrected distance visual acuity (bcdva) from 20/20 (preoperatively) to 20/25 at onset.At last examination on (b)(6) 2017, corneal haze persisted and bcdva decreased to 20/32.The inlay is scheduled for explantation on (b)(6) 2017.According to the surgeon, the patient's ocular history (dry eye and meibomian gland dysfunction) was a contributing factor.Additional information is being requested.
 
Manufacturer Narrative
The explanted inlay was returned to the manufacturer and subjected to visual microscopic inspection and dimensional analysis.The edge thickness and diameter were measured and found to be within specifications.Surface damage and particles were observed on the device, but these findings are consistent with findings for corneal inlays that have been explanted since surgical instruments are required to remove the device from the eye and place it in a hydrated storage container for transport.Complaint reference number: (b)(4).
 
Event Description
Rvo received new information indicating that the inlay was explanted on (b)(6) 2017.At last examination one month post-explant, there was some residual (trace) corneal haze and bcdva remained at 20/32.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
CORNEAL INLAY
Manufacturer (Section D)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer (Section G)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer Contact
pushpita singh
25651 atlantic ocean dr.,
ste. a1
lake forest, CA 92630-8835
9497072740
MDR Report Key6798670
MDR Text Key82841554
Report Number3005956347-2017-00089
Device Sequence Number1
Product Code LQE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
G090149
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date09/01/2013
Device Model NumberPP6-530-0027-US
Device Lot Number002371
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/21/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/17/2017
Initial Date FDA Received08/16/2017
Supplement Dates Manufacturer Received10/11/2017
Supplement Dates FDA Received10/12/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/21/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-